Beta Bionics, Inc. (BBNX)
16.92
+1.22
(+7.80%)
USD |
NASDAQ |
Nov 09, 16:00
16.92
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Net Income (Quarterly) : -24.35M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -24.35M |
| June 30, 2026 | -23.40M |
| March 31, 2026 | -21.90M |
| December 31, 2025 | -13.47M |
| September 30, 2025 | -14.21M |
| June 30, 2025 | -16.87M |
| March 31, 2025 | -28.66M |
| Date | Value |
|---|---|
| December 31, 2024 | -18.11M |
| September 30, 2024 | -9.736M |
| June 30, 2024 | -14.46M |
| March 31, 2024 | -12.45M |
| December 31, 2023 | -18.85M |
| September 30, 2023 | -8.68M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | -26.52M |
| Edwards Lifesciences Corp. | 301.40M |
| Intuitive Surgical, Inc. | 524.40M |
| Stryker Corp. | 753.00M |
| Zimmer Biomet Holdings, Inc. | 192.90M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 35.50M |
| Total Expenses (Quarterly) | 59.86M |
| EPS Diluted (Quarterly) | -0.5232 |
| Enterprise Value | 619.30M |
| Gross Profit Margin (Quarterly) | 57.26% |
| Profit Margin (Quarterly) | -68.59% |
| Earnings Yield | -10.91% |
| Normalized Earnings Yield | -10.91 |